461 related articles for article (PubMed ID: 17005846)
1. Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.
Ahmed D; D'Costa LT; Alam K; Nair GB; Hossain MA
Antimicrob Agents Chemother; 2006 Oct; 50(10):3516-7. PubMed ID: 17005846
[No Abstract] [Full Text] [Related]
2. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh.
Rahman MM; Haq JA; Morshed MA; Rahman MA
Int J Antimicrob Agents; 2005 Apr; 25(4):345-6. PubMed ID: 15784317
[No Abstract] [Full Text] [Related]
3. Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh.
Saha SK; Darmstadt GL; Baqui AH; Crook DW; Islam MN; Islam M; Hossain M; El Arifeen S; Santosham M; Black RE
J Clin Microbiol; 2006 Oct; 44(10):3811-3. PubMed ID: 17021117
[TBL] [Abstract][Full Text] [Related]
4. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
Gupta V; Kaur J; Kaistha N
Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries.
Chuang CH; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; VAN PH; Chongthaleong A; Hsueh PR; Liu JW; Song JH; Chiu CH
Epidemiol Infect; 2009 Feb; 137(2):266-9. PubMed ID: 18474127
[TBL] [Abstract][Full Text] [Related]
7. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
[TBL] [Abstract][Full Text] [Related]
9.
Tanmoy AM; Westeel E; De Bruyne K; Goris J; Rajoharison A; Sajib MSI; van Belkum A; Saha SK; Komurian-Pradel F; Endtz HP
mBio; 2018 Nov; 9(6):. PubMed ID: 30425150
[TBL] [Abstract][Full Text] [Related]
10. Scattergram analysis to explore the emerging problem related to in vitro susceptibility test for Salmonella enterica serovar Typhi to ciprofloxacin.
Pal NK; Mandal S; Mandal MD
Int J Antimicrob Agents; 2004 Sep; 24(3):297-9. PubMed ID: 15325437
[TBL] [Abstract][Full Text] [Related]
11. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
Krishnan P; Stalin M; Balasubramanian S
Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
[TBL] [Abstract][Full Text] [Related]
12. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.
Mengo DM; Kariuki S; Muigai A; Revathi G
J Infect Dev Ctries; 2010 Jun; 4(6):393-6. PubMed ID: 20601792
[TBL] [Abstract][Full Text] [Related]
13. Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.
Dutta S; Sur D; Manna B; Sen B; Bhattacharya M; Bhattacharya SK; Wain J; Nair S; Clemens JD; Ochiai RL
Int J Antimicrob Agents; 2008 Apr; 31(4):387-9. PubMed ID: 18280709
[No Abstract] [Full Text] [Related]
14. In vitro activity of gentamicin and amikacin against Salmonella enterica serovar Typhi: a search for a treatment regimen for typhoid fever.
Mandal S; Mandal MD; Pal NK
East Mediterr Health J; 2009; 15(2):264-8. PubMed ID: 19554971
[TBL] [Abstract][Full Text] [Related]
15. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
[No Abstract] [Full Text] [Related]
16. Multidrug resistant Salmonella typhi in Rourkela, Orissa.
Das U; Bhattacharya SS
Indian J Pathol Microbiol; 2000 Apr; 43(2):135-8. PubMed ID: 11217269
[TBL] [Abstract][Full Text] [Related]
17. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
Lee CJ; Su LH; Huang YC; Chiu CH
J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
[TBL] [Abstract][Full Text] [Related]
18. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh.
Asna SM; Haq JA; Rahman MM
Jpn J Infect Dis; 2003 Feb; 56(1):32-3. PubMed ID: 12711825
[No Abstract] [Full Text] [Related]
19. Chromosome-mediated multidrug resistance in Salmonella enterica serovar Typhi.
Chiou CS; Alam M; Kuo JC; Liu YY; Wang PJ
Antimicrob Agents Chemother; 2015 Jan; 59(1):721-3. PubMed ID: 25367917
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria.
Akinyemi KO; Smith SI; Oyefolu AO; Coker AO
Public Health; 2005 Apr; 119(4):321-7. PubMed ID: 15733694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
